{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:38:48Z","timestamp":1786991928323,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016925","name":"Takeda Foundation","doi-asserted-by":"publisher","award":["2023"],"award-info":[{"award-number":["2023"]}],"id":[{"id":"10.13039\/100016925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016925","name":"Takeda Foundation","doi-asserted-by":"publisher","award":["2023"],"award-info":[{"award-number":["2023"]}],"id":[{"id":"10.13039\/100016925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["Grant No 23K7651"],"award-info":[{"award-number":["Grant No 23K7651"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute cholangitis is a severe, life-threatening infection of the biliary system that requires early diagnosis and treatment. The Tokyo Guidelines recommend a combination of clinical, laboratory, and imaging findings for diagnosis and severity assessment, but there are still challenges in identifying severe cases that need immediate intervention. The microbiota and its derived products have been implicated in the pathogenesis of acute cholangitis. Corisin is a microbiome-derived peptide that induces cell apoptosis, acute tissue injury, and inflammation. This study aimed to evaluate the potential of plasma and bile corisin as a biomarker of acute cholangitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Forty patients with acute cholangitis associated with choledocholithiasis or malignant disease were enrolled. Nine patients without acute cholangitis were used as controls. Corisin was measured by enzyme immunoassays in plasma and bile samples. Patients were classified into severe and non-severe groups. The associations of plasma and bile corisin with the clinical grade of acute cholangitis and other parameters were analyzed by univariate and multivariate regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Plasma and bile corisin levels were significantly higher in patients with acute cholangitis than in controls. Patients with severe acute cholangitis had significantly higher plasma and bile corisin levels than those with non-severe form of the disease. Bile corisin level was significantly correlated with markers of inflammation, coagulation, fibrinolysis, and renal function. Univariate analysis revealed a significant association of bile corisin but a weak association of plasma corisin with the clinical grade of acute cholangitis. In contrast, multivariate analysis showed a significant relationship between plasma corisin level and the disease clinical grade. The receiver operating characteristic curve analysis showed low sensitivity but high specificity for plasma and bile corisin to detect the severity of acute cholangitis. The plasma and bile corisin sensitivity was increased when serum C-reactive protein level was included in the receiver operating characteristic curve analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, these findings suggest that plasma and bile corisin levels may be useful biomarkers for diagnosing and monitoring acute cholangitis and that corisin may play a role in the pathophysiology of the disease by modulating inflammatory, coagulation and renal pathways.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13099-023-00587-4","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T06:01:51Z","timestamp":1701324111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis"],"prefix":"10.1186","volume":"15","author":[{"given":"Ryo","family":"Nishiwaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Yasuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina N.","family":"D\u2019Alessandro-Gabazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hataji","family":"Osamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Fujibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Sugimasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Noji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Cann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban C.","family":"Gabazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"issue":"1","key":"587_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4291\/wjgp.v9.i1.1","volume":"9","author":"M Ahmed","year":"2018","unstructured":"Ahmed M. Acute cholangitis: an update. World J Gastrointest Pathophysiol. 2018;9(1):1\u20137. https:\/\/doi.org\/10.4291\/wjgp.v9.i1.1.","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"6","key":"587_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/jhbp.452","volume":"24","author":"H Gomi","year":"2017","unstructured":"Gomi H, Takada T, Hwang TL, Akazawa K, Mori R, Endo I, et al. Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis. J Hepatobiliary Pancreat Sci. 2017;24(6):310\u20138. https:\/\/doi.org\/10.1002\/jhbp.452.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"587_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.14218\/JCTH.2017.00028","volume":"5","author":"AH Mohammad Alizadeh","year":"2017","unstructured":"Mohammad Alizadeh AH. Cholangitis diagnosis, treatment and prognosis. J Clin Transl Hepatol. 2017;5(4):404\u201313. https:\/\/doi.org\/10.14218\/JCTH.2017.00028.","journal-title":"J Clin Transl Hepatol."},{"issue":"1","key":"587_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00534-012-0564-0","volume":"20","author":"Y Kimura","year":"2013","unstructured":"Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ, et al. TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):8\u201323. https:\/\/doi.org\/10.1007\/s00534-012-0564-0.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"19","key":"587_CR5","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3748\/wjg.v29.i19.3027","volume":"29","author":"K Kasparian","year":"2023","unstructured":"Kasparian K, Christou CD, Petidis K, Doumas M, Giouleme O. Short vs long-course antibiotic therapy in adults with acute cholangitis: a systematic review, meta-analysis, and evidence quality assessment. World J Gastroenterol. 2023;29(19):3027\u201339. https:\/\/doi.org\/10.3748\/wjg.v29.i19.3027.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"587_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jhbp.512","volume":"25","author":"S Kiriyama","year":"2018","unstructured":"Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17\u201330. https:\/\/doi.org\/10.1002\/jhbp.512.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"10","key":"587_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.cgh.2012.03.029","volume":"10","author":"MA Khashab","year":"2012","unstructured":"Khashab MA, Tariq A, Tariq U, Kim K, Ponor L, Lennon AM, et al. Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis. Clin Gastroenterol Hepatol. 2012;10(10):1157\u201361. https:\/\/doi.org\/10.1016\/j.cgh.2012.03.029.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"587_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/apt.13764","volume":"44","author":"CJ Karvellas","year":"2016","unstructured":"Karvellas CJ, Abraldes JG, Zepeda-Gomez S, Moffat DC, Mirzanejad Y, Vazquez-Grande G, et al. The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock. Aliment Pharmacol Ther. 2016;44(7):755\u201366. https:\/\/doi.org\/10.1111\/apt.13764.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"587_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.29337\/ijsp.170","volume":"26","author":"O Al-Yahri","year":"2022","unstructured":"Al-Yahri O, Al-Zoubi RM, Elhuda AA, Ahmad A, Al Dhaheri M, Abdelaziem S, et al. Diagnostic inflammation biomarkers for prediction of 30-day mortality rate in acute cholangitis. Int J Surg Protoc. 2022;26(1):14\u201321. https:\/\/doi.org\/10.29337\/ijsp.170.","journal-title":"Int J Surg Protoc."},{"issue":"5","key":"587_CR10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020\u201332. https:\/\/doi.org\/10.1136\/gutjnl-2021-326789.","journal-title":"Gut"},{"issue":"1","key":"587_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","volume":"18","author":"R Wang","year":"2021","unstructured":"Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol. 2021;18(1):4\u201317. https:\/\/doi.org\/10.1038\/s41423-020-00592-6.","journal-title":"Cell Mol Immunol"},{"key":"587_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12061068","author":"F Di Vincenzo","year":"2023","unstructured":"Di Vincenzo F, Nicoletti A, Negri M, Vitale F, Zileri Dal Verme L, Gasbarrini A, et al. Gut microbiota and antibiotic treatments for the main non-oncologic hepato-biliary-pancreatic disorders. Antibiotics (Basel). 2023. https:\/\/doi.org\/10.3390\/antibiotics12061068.","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"587_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jviscsurg.2019.05.007","volume":"156","author":"A Sokal","year":"2019","unstructured":"Sokal A, Sauvanet A, Fantin B, de Lastours V. Acute cholangitis: diagnosis and management. J Visc Surg. 2019;156(6):515\u201325. https:\/\/doi.org\/10.1016\/j.jviscsurg.2019.05.007.","journal-title":"J Visc Surg"},{"issue":"1","key":"587_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/den.14379","volume":"35","author":"S Mukai","year":"2023","unstructured":"Mukai S, Itoi T, Tsuchiya T, Ishii K, Tanaka R, Tonozuka R, et al. Urgent and emergency endoscopic retrograde cholangiopancreatography for gallstone-induced acute cholangitis and pancreatitis. Dig Endosc. 2023;35(1):47\u201357. https:\/\/doi.org\/10.1111\/den.14379.","journal-title":"Dig Endosc"},{"key":"587_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.625589","volume":"11","author":"J Han","year":"2021","unstructured":"Han J, Wu S, Fan Y, Tian Y, Kong J. Biliary microbiota in choledocholithiasis and correlation with duodenal microbiota. Front Cell Infect Microbiol. 2021;11: 625589. https:\/\/doi.org\/10.3389\/fcimb.2021.625589.","journal-title":"Front Cell Infect Microbiol"},{"key":"587_CR16","doi-asserted-by":"publisher","first-page":"1092563","DOI":"10.1155\/2019\/1092563","volume":"2019","author":"B Chen","year":"2019","unstructured":"Chen B, Fu SW, Lu L, Zhao H. A preliminary study of biliary microbiota in patients with bile duct stones or distal cholangiocarcinoma. Biomed Res Int. 2019;2019:1092563. https:\/\/doi.org\/10.1155\/2019\/1092563.","journal-title":"Biomed Res Int"},{"key":"587_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8060835","author":"IN Grigor'eva","year":"2020","unstructured":"Grigor\u2019eva IN, Romanova TI. Gallstone disease and microbiome. Microorganisms. 2020. https:\/\/doi.org\/10.3390\/microorganisms8060835.","journal-title":"Microorganisms"},{"issue":"2","key":"587_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12072-021-10231-5","volume":"16","author":"Z Hao","year":"2022","unstructured":"Hao Z, Tao K, Wu K, Luo Y, Lu Y, Li B, et al. Alterations of gut microbiome and metabolite profiles in choledocholithiasis concurrent with cholangitis. Hepatol Int. 2022;16(2):447\u201362. https:\/\/doi.org\/10.1007\/s12072-021-10231-5.","journal-title":"Hepatol Int"},{"issue":"12","key":"587_CR19","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","volume":"65","author":"H Tilg","year":"2016","unstructured":"Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65(12):2035\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2016-312729.","journal-title":"Gut"},{"key":"587_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/1471-2164-14-669","volume":"14","author":"T Wu","year":"2013","unstructured":"Wu T, Zhang Z, Liu B, Hou D, Liang Y, Zhang J, et al. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study. BMC Genomics. 2013;14:669. https:\/\/doi.org\/10.1186\/1471-2164-14-669.","journal-title":"BMC Genomics"},{"issue":"5","key":"587_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jhbp.931","volume":"28","author":"MA Beltran","year":"2021","unstructured":"Beltran MA, Beltran AA. Common bile duct pressure in patients with and without cholelithiasis: a case-control study. J Hepatobiliary Pancreat Sci. 2021;28(5):443\u20139. https:\/\/doi.org\/10.1002\/jhbp.931.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"587_CR22","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.gie.2015.03.1908","volume":"82","author":"R Zhang","year":"2015","unstructured":"Zhang R, Luo H, Pan Y, Zhao L, Dong J, Liu Z, et al. Rate of duodenal-biliary reflux increases in patients with recurrent common bile duct stones: evidence from barium meal examination. Gastrointest Endosc. 2015;82(4):660\u20135. https:\/\/doi.org\/10.1016\/j.gie.2015.03.1908.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"587_CR23","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/0016-5085(79)90158-6","volume":"77","author":"A Csendes","year":"1979","unstructured":"Csendes A, Kruse A, Funch-Jensen P, Oster MJ, Ornsholt J, Amdrup E. Pressure measurements in the biliary and pancreatic duct systems in controls and in patients with gallstones, previous cholecystectomy, or common bile duct stones. Gastroenterology. 1979;77(6):1203\u201310.","journal-title":"Gastroenterology"},{"issue":"1","key":"587_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41467-020-15344-3","volume":"11","author":"CN D'Alessandro-Gabazza","year":"2020","unstructured":"D\u2019Alessandro-Gabazza CN, Kobayashi T, Yasuma T, Toda M, Kim H, Fujimoto H, et al. A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis. Nat Commun. 2020;11(1):1539. https:\/\/doi.org\/10.1038\/s41467-020-15344-3.","journal-title":"Nat Commun"},{"issue":"1","key":"587_CR25","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/s41467-022-29064-3","volume":"13","author":"CN D'Alessandro-Gabazza","year":"2022","unstructured":"D\u2019Alessandro-Gabazza CN, Yasuma T, Kobayashi T, Toda M, Abdel-Hamid AM, Fujimoto H, et al. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis. Nat Commun. 2022;13(1):1558. https:\/\/doi.org\/10.1038\/s41467-022-29064-3.","journal-title":"Nat Commun"},{"issue":"6","key":"587_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ajpath.2023.03.003","volume":"193","author":"V Fridman D'Alessandro","year":"2023","unstructured":"Fridman D\u2019Alessandro V, D\u2019Alessandro-Gabazza CN, Yasuma T, Toda M, Takeshita A, Tomaru A, et al. Inhibition of a microbiota-derived peptide ameliorates established acute lung injury. Am J Pathol. 2023;193(6):740\u201354. https:\/\/doi.org\/10.1016\/j.ajpath.2023.03.003.","journal-title":"Am J Pathol"},{"issue":"5","key":"587_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41418-023-01153-w","volume":"30","author":"I Vitale","year":"2023","unstructured":"Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, et al. Apoptotic cell death in disease-current understanding of the NCCD 2023. Cell Death Differ. 2023;30(5):1097\u2013154. https:\/\/doi.org\/10.1038\/s41418-023-01153-w.","journal-title":"Cell Death Differ"},{"issue":"3","key":"587_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12016-012-8324-0","volume":"43","author":"K Kawata","year":"2012","unstructured":"Kawata K, Kobayashi Y, Gershwin ME, Bowlus CL. The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis. Clin Rev Allergy Immunol. 2012;43(3):230\u201341. https:\/\/doi.org\/10.1007\/s12016-012-8324-0.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"587_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/jhbp.1275","volume":"30","author":"U Farooq","year":"2023","unstructured":"Farooq U, Gondal AB, Franco D, Tarar ZI, Mahmood S. Validation of Tokyo guidelines 2018 for safety and mortality benefit from urgent ERCP in acute cholangitis across different age groups. J Hepatobiliary Pancreat Sci. 2023;30(6):737\u201344. https:\/\/doi.org\/10.1002\/jhbp.1275.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"7","key":"587_CR30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27527","volume":"14","author":"A Hudgi","year":"2022","unstructured":"Hudgi A, Cartelle AL, Ahmed A, Alkaddour A, Palacio C, Vega KJ, et al. Tokyo guidelines (TG18) for acute cholangitis provide improved specificity and accuracy compared to fellow assessment. Cureus. 2022;14(7): e27527. https:\/\/doi.org\/10.7759\/cureus.27527.","journal-title":"Cureus"},{"key":"587_CR31","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3389\/fmicb.2018.01892","volume":"9","author":"CN D'Alessandro-Gabazza","year":"2018","unstructured":"D\u2019Alessandro-Gabazza CN, Mendez-Garcia C, Hataji O, Westergaard S, Watanabe F, Yasuma T, et al. Identification of halophilic microbes in lung fibrotic tissue by oligotyping. Front Microbiol. 2018;9:1892. https:\/\/doi.org\/10.3389\/fmicb.2018.01892.","journal-title":"Front Microbiol."},{"issue":"4","key":"587_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/archsurg.1996.01430160047008","volume":"131","author":"A Csendes","year":"1996","unstructured":"Csendes A, Burdiles P, Maluenda F, Diaz JC, Csendes P, Mitru N. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch Surg. 1996;131(4):389\u201394. https:\/\/doi.org\/10.1001\/archsurg.1996.01430160047008.","journal-title":"Arch Surg"},{"issue":"5","key":"587_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/00365521.1976.12097131","volume":"11","author":"ML Nielsen","year":"1976","unstructured":"Nielsen ML, Justesen T. Anaerobic and aerobic bacteriological studies in biliary tract disease. Scand J Gastroenterol. 1976;11(5):437\u201346.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"587_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.15403\/jgld-4634","volume":"32","author":"PB Podgorski","year":"2023","unstructured":"Podgorski PB, Przybylkowski A, Nehring P. Bile composition\u2014which components can have clinical significance? A review of the literature. J Gastrointestin Liver Dis. 2023;32(1):110\u20137. https:\/\/doi.org\/10.15403\/jgld-4634.","journal-title":"J Gastrointestin Liver Dis."},{"issue":"3","key":"587_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000431071","volume":"31","author":"J Verdier","year":"2015","unstructured":"Verdier J, Luedde T, Sellge G. Biliary mucosal barrier and microbiome. Viszeralmedizin. 2015;31(3):156\u201361. https:\/\/doi.org\/10.1159\/000431071.","journal-title":"Viszeralmedizin"},{"issue":"5","key":"587_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/s0168-8278(01)00059-9","volume":"34","author":"H Baum","year":"2001","unstructured":"Baum H, Bogdanos DP, Vergani D. Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope. J Hepatol. 2001;34(5):785\u20137. https:\/\/doi.org\/10.1016\/s0168-8278(01)00059-9.","journal-title":"J Hepatol"},{"issue":"1","key":"587_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00000658-196607000-00010","volume":"164","author":"T Maki","year":"1966","unstructured":"Maki T. Pathogenesis of calcium bilirubinate gallstone: role of E. coli, beta-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg. 1966;164(1):90\u2013100. https:\/\/doi.org\/10.1097\/00000658-196607000-00010.","journal-title":"Ann Surg."},{"issue":"4","key":"587_CR38","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1053\/j.gastro.2005.01.008","volume":"128","author":"KJ Maurer","year":"2005","unstructured":"Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, et al. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology. 2005;128(4):1023\u201333. https:\/\/doi.org\/10.1053\/j.gastro.2005.01.008.","journal-title":"Gastroenterology"},{"issue":"6","key":"587_CR39","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/gut.2008.157818","volume":"59","author":"B Terjung","year":"2010","unstructured":"Terjung B, Sohne J, Lechtenberg B, Gottwein J, Muennich M, Herzog V, et al. p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ. Gut. 2010;59(6):808\u201316. https:\/\/doi.org\/10.1136\/gut.2008.157818.","journal-title":"Gut"},{"issue":"9","key":"587_CR40","doi-asserted-by":"publisher","first-page":"851 e1\u20139","DOI":"10.1016\/j.cmi.2015.05.017","volume":"21","author":"J Liu","year":"2015","unstructured":"Liu J, Yan Q, Luo F, Shang D, Wu D, Zhang H, et al. Acute cholecystitis associated with infection of Enterobacteriaceae from gut microbiota. Clin Microbiol Infect. 2015;21(9):851 e1-9. https:\/\/doi.org\/10.1016\/j.cmi.2015.05.017.","journal-title":"Clin Microbiol Infect."},{"issue":"3","key":"587_CR41","doi-asserted-by":"publisher","first-page":"G571","DOI":"10.1152\/ajpgi.00537.2004","volume":"289","author":"P Brun","year":"2005","unstructured":"Brun P, Castagliuolo I, Pinzani M, Palu G, Martines D. Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2005;289(3):G571\u20138. https:\/\/doi.org\/10.1152\/ajpgi.00537.2004.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"587_CR42","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1016\/j.bbadis.2019.06.016","volume":"1865","author":"Y Chen","year":"2019","unstructured":"Chen Y, Weng Z, Liu Q, Shao W, Guo W, Chen C, et al. FMO3 and its metabolite TMAO contribute to the formation of gallstones. Biochim Biophys Acta Mol Basis Dis. 2019;1865(10):2576\u201385. https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.016.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"587_CR43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.20524\/aog.2023.0809","volume":"36","author":"S Rahman","year":"2023","unstructured":"Rahman S, O\u2019Connor AL, Becker SL, Patel RK, Martindale RG, Tsikitis VL. Gut microbial metabolites and its impact on human health. Ann Gastroenterol. 2023;36(4):360\u20138. https:\/\/doi.org\/10.20524\/aog.2023.0809.","journal-title":"Ann Gastroenterol."},{"issue":"3","key":"587_CR44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/s0168-8278(98)80058-5","volume":"29","author":"K Sasatomi","year":"1998","unstructured":"Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol. 1998;29(3):409\u201316. https:\/\/doi.org\/10.1016\/s0168-8278(98)80058-5.","journal-title":"J Hepatol"},{"issue":"2","key":"587_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/s0168-8278(01)00084-8","volume":"35","author":"K Tsuneyama","year":"2001","unstructured":"Tsuneyama K, Harada K, Kono N, Hiramatsu K, Zen Y, Sudo Y, et al. Scavenger cells with gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis. J Hepatol. 2001;35(2):156\u201363. https:\/\/doi.org\/10.1016\/s0168-8278(01)00084-8.","journal-title":"J Hepatol"},{"key":"587_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112885","author":"H Saiki","year":"2021","unstructured":"Saiki H, Okano Y, Yasuma T, Toda M, Takeshita A, Abdel-Hamid AM, et al. A microbiome-derived peptide induces apoptosis of cells from different tissues. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10112885.","journal-title":"Cells."},{"key":"587_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2023.2231585","author":"HF Fridgeirsson","year":"2023","unstructured":"Fridgeirsson HF, Konradsson M, Vesteinsdottir E, Bjornsson ES. Incidence and outcomes in patients with acute cholangitis: a population-based study. Scand J Gastroenterol. 2023. https:\/\/doi.org\/10.1080\/00365521.2023.2231585.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"587_CR48","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1038\/s41598-021-82603-8","volume":"11","author":"SW Suh","year":"2021","unstructured":"Suh SW, Choi YS, Choi SH, Do JH, Oh HC, Kim HJ, et al. Antibiotic selection based on microbiology and resistance profiles of bile from gallbladder of patients with acute cholecystitis. Sci Rep. 2021;11(1):2969. https:\/\/doi.org\/10.1038\/s41598-021-82603-8.","journal-title":"Sci Rep"},{"issue":"9","key":"587_CR49","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1007\/s10620-018-4963-1","volume":"63","author":"YS Lee","year":"2018","unstructured":"Lee YS, Cho KB, Park KS, Lee JY, Lee YJ. Procalcitonin as a decision-supporting marker of urgent biliary decompression in acute cholangitis. Dig Dis Sci. 2018;63(9):2474\u20139. https:\/\/doi.org\/10.1007\/s10620-018-4963-1.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"587_CR50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/jhbp.132","volume":"21","author":"S Shinya","year":"2014","unstructured":"Shinya S, Sasaki T, Yamashita Y, Kato D, Yamashita K, Nakashima R, et al. Procalcitonin as a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis. J Hepatobiliary Pancreat Sci. 2014;21(10):777\u201385. https:\/\/doi.org\/10.1002\/jhbp.132.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"587_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051155","author":"K Silangcruz","year":"2022","unstructured":"Silangcruz K, Nishimura Y, Czech T, Kimura N, Yess J. Procalcitonin to predict severity of acute cholangitis and need for urgent biliary decompression: systematic scoping review. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11051155.","journal-title":"J Clin Med."},{"issue":"2","key":"587_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/jhbp.420","volume":"24","author":"Y Suwa","year":"2017","unstructured":"Suwa Y, Matsuyama R, Goto K, Kadokura T, Sato M, Mori R, et al. IL-7 and procalcitonin are useful biomarkers in the comprehensive evaluation of the severity of acute cholangitis. J Hepatobiliary Pancreat Sci. 2017;24(2):81\u20138. https:\/\/doi.org\/10.1002\/jhbp.420.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"6","key":"587_CR53","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00535-016-1278-x","volume":"52","author":"G Umefune","year":"2017","unstructured":"Umefune G, Kogure H, Hamada T, Isayama H, Ishigaki K, Takagi K, et al. Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study. J Gastroenterol. 2017;52(6):734\u201345. https:\/\/doi.org\/10.1007\/s00535-016-1278-x.","journal-title":"J Gastroenterol"},{"key":"587_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cca.2022.05.022","volume":"533","author":"X Deng","year":"2022","unstructured":"Deng X, Wang JW, Wu Q, Pan L, Mou T, Du CY. Lipocalin2 as a useful biomarker for risk stratification in patients with acute cholangitis: a single-center prospective and observational study. Clin Chim Acta. 2022;533:22\u201330. https:\/\/doi.org\/10.1016\/j.cca.2022.05.022.","journal-title":"Clin Chim Acta"},{"key":"587_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.1343","author":"H Oura","year":"2023","unstructured":"Oura H, Nishino T, Murakami D, Shima Y, Shirato M, Sugiyama H, et al. Diagnostic value of the serum lactate level as a predictor of bacteremia in patients with acute cholangitis. J Hepatobiliary Pancreat Sci. 2023. https:\/\/doi.org\/10.1002\/jhbp.1343.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"587_CR56","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jiac.2020.11.013","volume":"27","author":"T Tsuchida","year":"2021","unstructured":"Tsuchida T, Ie K, Okuse C, Hirose M, Nishisako H, Torikai K, et al. Determining the factors affecting serum presepsin level and its diagnostic utility: A cross-sectional study. J Infect Chemother. 2021;27(4):585\u201391. https:\/\/doi.org\/10.1016\/j.jiac.2020.11.013.","journal-title":"J Infect Chemother"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-023-00587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-023-00587-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-023-00587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T06:01:59Z","timestamp":1701324119000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-023-00587-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1186\/s13099-023-00587-4","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"3 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects participating in the clinical investigation provided written informed consent, and the study protocol was approved by the Ethical Committees for Clinical Investigation of Mie University (Approval No: U2022-012, date: 19\/05\/2022), Doshinkai Tohyama Hospital and conducted following the Principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"E.C.G. and T.Y. received a Research Grant from Takeda Foundation. None of the other authors declared any competing interest regarding the data reported in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}